Cargando…
Evolutionary engineering of E. coli MG1655 for tolerance against isoprenol
BACKGROUND: Isoprenol is the basis for industrial flavor and vitamin synthesis and also a promising biofuel. Biotechnological production of isoprenol with E. coli is currently limited by the high toxicity of the final product. Adaptive laboratory evolution (ALE) is a promising method to address comp...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653855/ https://www.ncbi.nlm.nih.gov/pubmed/33292484 http://dx.doi.org/10.1186/s13068-020-01825-6 |
_version_ | 1783607959119462400 |
---|---|
author | Babel, Heiko Krömer, Jens O. |
author_facet | Babel, Heiko Krömer, Jens O. |
author_sort | Babel, Heiko |
collection | PubMed |
description | BACKGROUND: Isoprenol is the basis for industrial flavor and vitamin synthesis and also a promising biofuel. Biotechnological production of isoprenol with E. coli is currently limited by the high toxicity of the final product. Adaptive laboratory evolution (ALE) is a promising method to address complex biological problems such as toxicity. RESULTS: Here we applied this method successfully to evolve E. coli towards higher tolerance against isoprenol, increasing growth at the half-maximal inhibitory concentration by 47%. Whole-genome re-sequencing of strains isolated from three replicate evolutions at seven time-points identified four major target genes for isoprenol tolerance: fabF, marC, yghB, and rob. We could show that knock-out of marC and expression of mutated Rob H(48) → frameshift increased tolerance against isoprenol and butanol. RNA-sequencing showed that the deletion identified upstream of yghB correlated with a strong overexpression of the gene. The knock-out of yghB demonstrated that it was essential for isoprenol tolerance. The mutated Rob protein and yghB deletion also lead to increased vanillin tolerance. CONCLUSION: Through ALE, novel targets for strain optimization in isoprenol production and also the production of other fuels, such as butanol, could be obtained. Their effectiveness could be shown through re-engineering. This paves the way for further optimization of E. coli for biofuel production. |
format | Online Article Text |
id | pubmed-7653855 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76538552020-11-10 Evolutionary engineering of E. coli MG1655 for tolerance against isoprenol Babel, Heiko Krömer, Jens O. Biotechnol Biofuels Research BACKGROUND: Isoprenol is the basis for industrial flavor and vitamin synthesis and also a promising biofuel. Biotechnological production of isoprenol with E. coli is currently limited by the high toxicity of the final product. Adaptive laboratory evolution (ALE) is a promising method to address complex biological problems such as toxicity. RESULTS: Here we applied this method successfully to evolve E. coli towards higher tolerance against isoprenol, increasing growth at the half-maximal inhibitory concentration by 47%. Whole-genome re-sequencing of strains isolated from three replicate evolutions at seven time-points identified four major target genes for isoprenol tolerance: fabF, marC, yghB, and rob. We could show that knock-out of marC and expression of mutated Rob H(48) → frameshift increased tolerance against isoprenol and butanol. RNA-sequencing showed that the deletion identified upstream of yghB correlated with a strong overexpression of the gene. The knock-out of yghB demonstrated that it was essential for isoprenol tolerance. The mutated Rob protein and yghB deletion also lead to increased vanillin tolerance. CONCLUSION: Through ALE, novel targets for strain optimization in isoprenol production and also the production of other fuels, such as butanol, could be obtained. Their effectiveness could be shown through re-engineering. This paves the way for further optimization of E. coli for biofuel production. BioMed Central 2020-11-09 /pmc/articles/PMC7653855/ /pubmed/33292484 http://dx.doi.org/10.1186/s13068-020-01825-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Babel, Heiko Krömer, Jens O. Evolutionary engineering of E. coli MG1655 for tolerance against isoprenol |
title | Evolutionary engineering of E. coli MG1655 for tolerance against isoprenol |
title_full | Evolutionary engineering of E. coli MG1655 for tolerance against isoprenol |
title_fullStr | Evolutionary engineering of E. coli MG1655 for tolerance against isoprenol |
title_full_unstemmed | Evolutionary engineering of E. coli MG1655 for tolerance against isoprenol |
title_short | Evolutionary engineering of E. coli MG1655 for tolerance against isoprenol |
title_sort | evolutionary engineering of e. coli mg1655 for tolerance against isoprenol |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653855/ https://www.ncbi.nlm.nih.gov/pubmed/33292484 http://dx.doi.org/10.1186/s13068-020-01825-6 |
work_keys_str_mv | AT babelheiko evolutionaryengineeringofecolimg1655fortoleranceagainstisoprenol AT kromerjenso evolutionaryengineeringofecolimg1655fortoleranceagainstisoprenol |